Proactive Investors - Run By Investors For Investors
Market: AIM
52-week High/Low: 44.50p / 25.00p
Sector: Pharma & Biotech
Market Cap: 7.20M
Genedrive PLC

Genedrive PLC

The Genedrive® molecular diagnostic system has been developed as an affordable next generation genotyping and sequence analysis device, providing rapid detection in approximately 45-75 minutes depending on the test.
The first test developed on the Genedrive® is MTB/RIF which allows small/medium laboratories to test for TB thus speeding up diagnosis and treatment and improving prognosis.

Genedrive PLC

Interactive graph

col 3
col 4
col 5
col 6

Genedrive PLC Timeline

CN Video

Riccardo Lowi discusses Genedrive Plc

Riccardo Lowi, analyst at Capital Network on the launch preparation of Genedrive® HCV test with partner Sysmex on track, expect sales to start coming through in CY2018.
Overall Genedrive PLC (LON: GDR) reported a business and financial update for the six months to December 2017 in line with expectations Launch preparation of Genedrive® HCV test with partner Sysmex on track, expect sales to start coming through in CY2018 £1.3mln income from the ongoing collaboration with...
Genedrive (LON:GDR) on track to become a commercial stage, point-of-need diagnostics company Launch of Genedrive® Hepatitis C (HCV) test at IFCC World Lab October 2017, with commercial sales expected in the coming quarters (African markets) Distribution agreement signed for HCV test for Asia...
genedrive (GDR.LON), an emerging UK medtech company, focuses on the development and commercialization of an innovative, point-of-care diagnostic system, also called Genedrive® (in this report, "genedrive" (GDR.LON) refers to the company, whereas "Genedrive®" indicates the product). genedrive (GDR.LON) is poised to...

© Proactive Investors 2018

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use